+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Peanut Allergy Pipeline Analysis Report 2026 - Product Thumbnail Image

Peanut Allergy Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Uveitis Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Uveitis Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Rhinitis Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Rhinitis Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Moderate Psoriasis Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Moderate Psoriasis Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Hereditary Angioedema Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Hereditary Angioedema Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Systemic Sclerosis Pipeline Analysis Report 2026 - Product Thumbnail Image

Systemic Sclerosis Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 200 Pages
  • Global
From
Allergic Conjunctivitis Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Allergic Conjunctivitis Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Hereditary Angioedema Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Hereditary Angioedema Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Microscopic Polyangiitis Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Microscopic Polyangiitis Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
From
Ulcerative Colitis (UC) Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Ulcerative Colitis (UC) Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Kawasaki Disease Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Kawasaki Disease Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
From
From
Allergy Rhinitis Drugs Market 2026-2030 - Product Thumbnail Image

Allergy Rhinitis Drugs Market 2026-2030

  • Report
  • August 2026
  • 296 Pages
  • Global
From
Pd-1 and Pd-L1 Inhibitors Market 2026-2030 - Product Thumbnail Image

Pd-1 and Pd-L1 Inhibitors Market 2026-2030

  • Report
  • April 2026
  • 286 Pages
  • Global
From
Autoimmune Drugs Market 2026-2030 - Product Thumbnail Image

Autoimmune Drugs Market 2026-2030

  • Report
  • August 2026
  • 337 Pages
  • Global
From
Hyaluronic Acid Market 2026-2030 - Product Thumbnail Image

Hyaluronic Acid Market 2026-2030

  • Report
  • August 2026
  • 307 Pages
  • Global
From
Human Immunoglobulin Market 2026-2030 - Product Thumbnail Image

Human Immunoglobulin Market 2026-2030

  • Report
  • August 2026
  • 309 Pages
  • Global
From
Antibody Market 2026-2030 - Product Thumbnail Image

Antibody Market 2026-2030

  • Report
  • May 2026
  • 304 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more